Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Net Income (2019 - 2025)

Bioadaptives' Net Income history spans 7 years, with the latest figure at -$379502.0 for Q3 2025.

  • For Q3 2025, Net Income fell 908.0% year-over-year to -$379502.0; the TTM value through Sep 2025 reached -$1.2 million, down 411.34%, while the annual FY2024 figure was -$694068.0, 155.19% down from the prior year.
  • Net Income for Q3 2025 was -$379502.0 at Bioadaptives, down from -$157914.0 in the prior quarter.
  • Across five years, Net Income topped out at $19095.0 in Q4 2023 and bottomed at -$491903.0 in Q1 2021.
  • The 5-year median for Net Income is -$138754.0 (2022), against an average of -$189626.6.
  • The largest annual shift saw Net Income skyrocketed 116.34% in 2023 before it crashed 2196.72% in 2024.
  • A 5-year view of Net Income shows it stood at -$89602.0 in 2021, then plummeted by 30.41% to -$116851.0 in 2022, then surged by 116.34% to $19095.0 in 2023, then plummeted by 2196.72% to -$400369.0 in 2024, then increased by 5.21% to -$379502.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Net Income are -$379502.0 (Q3 2025), -$157914.0 (Q2 2025), and -$258478.0 (Q1 2025).